Vaccine Market Size, Share, Industry Analysis, Forecast and Global Research Report to 2027

Growing demand growth for infectious diseases and increased investment in vaccine development will drive the vaccine market.
VANCOUVER, British Columbia - June 16, 2021 - PRLog -- The global Vaccine Market size is forecasted to be worth USD 69.86 Billion by 2027, according to a current analysis by Emergen Research. An increase in the incidence of infectious diseases has boosted the adoption of the market for the vaccine. A rise in the prevalence of infectious diseases globally increases the burden of the disease on the country and affects their socio-economic development.The enhancement in technology has resulted in the emergence of drug-resistant microbial strains that have affected the fight against infectious diseases such as pneumonia, cholera, malaria, and diarrhea, among others.

Target Audience of the Global Vaccine Market Report:
  • Key Market Players
  • Investors
  • Venture capitalists
  • Small- and medium-sized and large enterprises
  • Third-party knowledge providers
  • Value-Added Resellers (VARs)
  • Global market producers, distributors, traders, and suppliers

Leading manufacturers profiled in the report:

Pfizer, Inc., CSL Limited, Merck & Co., Inc., AstraZeneca, Johnson & Johnson, Serum Institute of India Pvt., Ltd., GlaxoSmithKline PLC, Sanofi Pasteur SA, Emergent Biosolutions, Inc., and Biological E, among others.

For the purpose of this report, Emergen Research has segmented into the global Vaccine Market on the basis of type, patient type, technology, disease, route of administration, and region:
  • Type Outlook (Revenue, USD Billion; 2017-2027)
o   Monovalent Vaccines

o   Multivalent Vaccines
  • Patient Type Outlook (Revenue, USD Billion; 2017-2027)
o   Pediatric Patients

o   Adult Patients
  • Technology Outlook (Revenue, USD Billion; 2017-2027)
o   Inactivated & Subunit Vaccines

o   Conjugate Vaccines

o   Recombinant Vaccines

o   Live Attenuated Vaccines

o   Toxoid Vaccines
  • Disease Outlook (Revenue, USD Billion; 2017-2027)
o   DTP

o   HPV

o   Pneumococcal Disease

o   Meningococcal Disease

o   Influenza

o   Hepatitis

o   Varicella

o   MMR

o   Polio

o   Herpes Zoster

o   Rotavirus

o   Others
  • Route of Administration Outlook (Revenue, USD Billion; 2017-2027)
o   Oral Administration

o   Intramuscular and Subcutaneous Administration

o   Others

Read Full Report Description@

Emergen Research
Email:*** Email Verified
Tags:Vaccine Market
Location:Vancouver - British Columbia - Canada
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Emergen Research News
Most Viewed
Daily News

Like PRLog?
Click to Share